Showing results (51-60 of 185) with videos related to

Sort By:
Pageof 19
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1984
In vitro and in vivo interactions of recent cephalosporins with gentamicin and amikacinH Giamarellou, K Mavroudis, G Petrikkos, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1993
Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditisA Pefanis, H Giamarellou, P Karayiannakos, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1989
In-vitro activity of meropenem, a new carbapenem, against multiresistant Pseudomonas aeruginosa compared with that of other antipseudomonal antimicrobialsD Voutsinas, T Mavroudis, A Avlamis, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1989
Comparative in vitro activity of cefepime (BMY 28142) against multiresistant nosocomial isolates of Pseudomonas aeruginosaD Voutsinas, T Mavroudis, A Avlamis, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1996
Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistanceA Bauernfeind, I Stemplinger, R Jungwirth, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1996
In-vitro interactions of DX-8739, a new carbapenem, meropenem and imipenem with amikacin against multiresistant Pseudomonas aeruginosaE J Giamarellos-Bourboulis, P Grecka, H Giamarellou
Age and Ageing|July 1, 1987
Diuresis bacteriuria in physically dependent elderly womenA S Dontas, I Paraskaki, G Petrikkos, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1984
In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosaH Giamarellou, N P Zissis, G Tagari, et al.
Drugs Under Experimental and Clinical Research|January 1, 1985
Experience with ciprofloxacin in the treatment of various infections caused mainly by Pseudomonas aeruginosaH Giamarellou, E Daphnis, C Dendrinos, et al.
Arzneimittel-Forschung|January 1, 1979
Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinicG K Daikos, H Giamarellou, K Hadjipolydorou, et al.
Pageof 19